Connection

Evan Graboyes to Head and Neck Neoplasms

Back to Details
This is a "connection" page, showing publications Evan Graboyes has written about Head and Neck Neoplasms.
Evan Graboyes
Connection Strength
13.672
Head and Neck Neoplasms
  1. Efficacy of a Brief Tele-Cognitive Behavioral Treatment vs Attention Control for Head and Neck Cancer Survivors With Body Image Distress: A Pilot Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2023 01 01; 149(1):54-62.
    View in: PubMed
    Score: 0.563
  2. Head and Neck Oncology Is on the National Quality Sidelines No Longer-Put Me in, Coach. JAMA Otolaryngol Head Neck Surg. 2022 08 01; 148(8):715-716.
    View in: PubMed
    Score: 0.547
  3. Association Between Observer-Rated Disfigurement and Body Image-Related Distress Among Head and Neck Cancer Survivors. JAMA Otolaryngol Head Neck Surg. 2022 07 01; 148(7):688-689.
    View in: PubMed
    Score: 0.544
  4. Factors Associated With Risk of Body Image-Related Distress in Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2021 12 01; 147(12):1019-1026.
    View in: PubMed
    Score: 0.522
  5. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.497
  6. Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:1-11.
    View in: PubMed
    Score: 0.496
  7. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.495
  8. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.487
  9. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.479
  10. COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon. Head Neck. 2020 Jul; 42(7):1555-1559.
    View in: PubMed
    Score: 0.472
  11. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.471
  12. Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
    View in: PubMed
    Score: 0.469
  13. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.463
  14. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.458
  15. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.435
  16. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Prospective Cohort Pilot Study. Otolaryngol Head Neck Surg. 2019 07; 161(1):105-110.
    View in: PubMed
    Score: 0.432
  17. A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 06; 160(6):941-954.
    View in: PubMed
    Score: 0.430
  18. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.429
  19. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.403
  20. Evolution of the anterolateral thigh free flap. Curr Opin Otolaryngol Head Neck Surg. 2017 Oct; 25(5):416-421.
    View in: PubMed
    Score: 0.391
  21. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.389
  22. Head & neck reconstruction: Predictors of readmission. Oral Oncol. 2017 11; 74:159-162.
    View in: PubMed
    Score: 0.384
  23. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.376
  24. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.374
  25. Postoperative care fragmentation and thirty-day unplanned readmissions after head and neck cancer surgery. Laryngoscope. 2017 04; 127(4):868-874.
    View in: PubMed
    Score: 0.366
  26. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach. Head Neck. 2015 Nov; 37(11):1603-11.
    View in: PubMed
    Score: 0.316
  27. Quantifying Costs Associated With Survival Among Patients With Head and Neck Cancer-Reply. JAMA Otolaryngol Head Neck Surg. 2023 03 01; 149(3):285.
    View in: PubMed
    Score: 0.142
  28. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship. JAMA Otolaryngol Head Neck Surg. 2022 12 01; 148(12):1111-1119.
    View in: PubMed
    Score: 0.140
  29. Free tissue reconstruction in the "vessel-depleted" neck: A multi-institutional cohort study. Microsurgery. 2023 Mar; 43(3):205-212.
    View in: PubMed
    Score: 0.139
  30. Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression. Head Neck. 2022 07; 44(7):1520-1527.
    View in: PubMed
    Score: 0.134
  31. Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance. JAMA Otolaryngol Head Neck Surg. 2022 01 01; 148(1):43-51.
    View in: PubMed
    Score: 0.131
  32. Incidence and Risk of Suicide Among Patients With Head and Neck Cancer in Rural, Urban, and Metropolitan Areas. JAMA Otolaryngol Head Neck Surg. 2021 12 01; 147(12):1045-1052.
    View in: PubMed
    Score: 0.131
  33. Management of Flap Failure After Head and Neck Reconstruction: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2022 08; 167(2):224-235.
    View in: PubMed
    Score: 0.128
  34. Postoperative wound infections in head and neck surgery: The current state of antiseptic and antibiotic practices. Oral Oncol. 2021 07; 118:105361.
    View in: PubMed
    Score: 0.126
  35. The effect of reconstruction on positive margin rates in oral cancer: Using length of stay as a proxy measure for flap reconstruction in a national database. Am J Otolaryngol. 2021 Sep-Oct; 42(5):103012.
    View in: PubMed
    Score: 0.125
  36. Expanding Indications for the Human Papillomavirus Vaccine: One Small Step for the Prevention of Head and Neck Cancer, but One Giant Leap Remains. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1099-1101.
    View in: PubMed
    Score: 0.122
  37. Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic. Cancer. 2020 11 15; 126(22):4895-4904.
    View in: PubMed
    Score: 0.119
  38. Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction. JAMA Otolaryngol Head Neck Surg. 2019 12 01; 145(12):1150-1157.
    View in: PubMed
    Score: 0.114
  39. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.107
  40. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 02; 160(2):284-294.
    View in: PubMed
    Score: 0.104
  41. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.101
  42. Retropharyngeal Mass. JAMA Otolaryngol Head Neck Surg. 2017 04 01; 143(4):421-422.
    View in: PubMed
    Score: 0.094
  43. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.